Premier Alternatives

Tasca Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. Tasca Therapeutics is based in Cambridge, MA and was founded in 2022. It was valued at $83.3 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $67 million across 1 recorded round; the latest was a $48.1 million early-stage round in Nov 2024.

PMV mark · valuation
$83.3M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$67.0M
Last round
Early Stage VC
Nov 2024
How much has Tasca Therapeutics raised?
$67.0Macross 1 recorded rounds · Nov 2024 – Nov 2024

Most recently, Tasca Therapeutics raised $48.1M in its Early Stage VC (Nov 2024).

Free account
More of Tasca Therapeutics with a free account
  • ·Watch Tasca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tasca Therapeutics round by round

1 rounds
Nov 2024Early Stage VC$48.1MSEC filing▮
9 investors participated

How much has Tasca Therapeutics raised?

Tasca Therapeutics has raised $67 million in total; 1 of its rounds is on record. The largest on record was a $48.1 million early-stage round in Nov 2024.

Tasca Therapeutics has filed 1 Form D with the SEC, most recently in Nov 2024 ($24.1 million sold to 7 investors).

Tasca Therapeutics investors

7 investors are on record for Tasca Therapeutics, including 8VC, The Invus Group, TIFF Investment Management and AB Magnitude Ventures Group. The early-stage round in Nov 2024 drew 9 investors.

For fundraisers
Raising for a company like Tasca Therapeutics?

7 investors have backed Tasca Therapeutics.

See all 7 investors →

Frequently asked about Tasca Therapeutics

How much has Tasca Therapeutics raised?
Tasca Therapeutics has raised $67.0M in total across 1 recorded funding rounds.
When was Tasca Therapeutics's last funding round?
Tasca Therapeutics's most recent recorded round was Early Stage VC in Nov 2024, raising $48.1M.